- Home
- LSTA vs GRCE Comparison
LSTA vs GRCE Comparison
Compare LSTA & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- GRCE
- Stock Information
- Founded
- LSTA 1980
- GRCE 2002
- Country
- LSTA United States
- GRCE United States
- Employees
- LSTA N/A
- GRCE N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- GRCE
- Sector
- LSTA Health Care
- GRCE
- Exchange
- LSTA Nasdaq
- GRCE NYSE
- Market Cap
- LSTA 24.1M
- GRCE 42.1M
- IPO Year
- LSTA N/A
- GRCE N/A
- Fundamental
- Price
- LSTA $2.91
- GRCE $3.00
- Analyst Decision
- LSTA Strong Buy
- GRCE Strong Buy
- Analyst Count
- LSTA 1
- GRCE 1
- Target Price
- LSTA $15.00
- GRCE $12.00
- AVG Volume (30 Days)
- LSTA 21.4K
- GRCE 60.2K
- Earning Date
- LSTA 08-11-2025
- GRCE 08-15-2025
- Dividend Yield
- LSTA N/A
- GRCE N/A
- EPS Growth
- LSTA N/A
- GRCE N/A
- EPS
- LSTA N/A
- GRCE N/A
- Revenue
- LSTA $1,000,000.00
- GRCE N/A
- Revenue This Year
- LSTA N/A
- GRCE N/A
- Revenue Next Year
- LSTA N/A
- GRCE N/A
- P/E Ratio
- LSTA N/A
- GRCE N/A
- Revenue Growth
- LSTA N/A
- GRCE N/A
- 52 Week Low
- LSTA $1.87
- GRCE $1.75
- 52 Week High
- LSTA $4.20
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- LSTA 59.12
- GRCE N/A
- Support Level
- LSTA $2.34
- GRCE N/A
- Resistance Level
- LSTA $3.09
- GRCE N/A
- Average True Range (ATR)
- LSTA 0.26
- GRCE 0.00
- MACD
- LSTA 0.02
- GRCE 0.00
- Stochastic Oscillator
- LSTA 76.00
- GRCE 0.00
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.